JERUSALEM, Dec. 1 /PRNewswire-FirstCall/ -- IDenta Corp. (Pink Sheets: IDTA): Identa Corp CEO Yaacov Shoham today released this statement updating the presentation of Identa products at the 2009 Explosives Detection Symposium and Workshop.

Mr. Shoham stated, "Due to the efforts of Jant Pharmacal (Accutest), the presentation of Identa explosive test kits was extremely successful and well received.

"After five weeks since the presentations at this workshop, Identa and Jant Pharmacal (Identa's representative company in the states) are happy to release that we have obtained more than 40 leads.

"Many of them are from very important American law enforcement or military agencies like:

"FBI-Quantico, Department of Defense, Homeland Security, Analytical Microscopy Group National Institute of Standards and Technology, NavAIR, Naval Air Warfare Center Weapons Division, 930 CAST, US Army for Afghanistan and Iraq, Office of the Deputy Sec of Defense, US Customs and Border Protection, Bureau of Alcohol, Tobacco, Firearms and Explosives, etc.

"Some of the agencies are looking to conduct extensive tests with Identa's explosive detector kits.

"The other leads are local or state agencies (bomb squads) or from abroad ( Canada, Singapore, etc).

"All of the leads have received samples, info and training.

"Identa representatives have been in contact almost daily with many of the agencies, answering and giving them additional particular information.

"Despite the short period since the show, some of the agencies have already started to purchase Identa's Alert Explosive Detectors for using them in the field.

"During the show we also made strong connections with two large international companies which are manufacturing electronic devices to detect explosives. Those companies are looking to provide an inexpensive and reliable chemical explosive kit as a backup for the electronic devices.

"The electronic devices have false positives and are very expensive.

"Identa's Alert explosive kit is inexpensive, with immediate results, reliable, easy to use and can be a very good backup for the electronic device.

"We want to emphasize that the new connections developed at the San Diego workshop are in addition to the DOD test.

"We have been in the last few months in contact with the DOD officers to finalize the tests for Identa's Alert Explosive Detectors. Identa has helped them to develop and establish a special protocol how to use the explosive kits.

"The DOD test is still in progress, and hopefully will be concluded positive in a relatively short period.

"At The San Diego Explosive Detection 2009 Symposium and Workshop, in our opinion, we have been able to receive the best possible connections and exposure for Identa's Alert Explosive Detectors.

"Due to the high quality of the explosive detectors, Identa and Jant Pharmacal are confident that because of this workshop, we will be able in 2010 to make sales of the explosive detectors in a very large numbers, for many federal state and local agencies."

Mr. Shoham further added, "The interest level for our explosive test kits was exceptional and we will continue the relationships that we have established with these high level agencies. This meeting was the one that we targeted to gain worldwide exposure for test kits and we feel we have succeeded."

ABOUT IDENTA

Since 2003, IDenta Corporation has been recognized as a worldwide leader in the development of proprietary on-site drug, drug precursor and explosive detection kits. IDenta develops, manufactures and distributes products for both the professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

Information concerning IDenta's entire product line may be found at www.IDenta.biz

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

For Investor Relations, lobbying interests or information concerning IDenta's products internationally or the development of new chemical detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487, fpi@drugsdetector.com, www.identa.biz.

For information about the Accutest® - IDenta products in the US, please contact: Mr. Eyal Golan, COO, JANT PHARMACAL CORPORATION, 16255 Ventura Blvd. #505, Encino, CA 91436, Toll Free: 800-676-5565, 661-478-0582 (mobile), golan@accutest.net, www.accutestidenta.net.

Contact:
Yaacov Shoham
IDenta Corp.
CEO
Tel: +972-52-6554487
fpi@drugsdetector.com
http://www.identa.biz

SOURCE IDenta Corp.

Back to top

RELATED LINKS
http://www.identa.biz